MapLight Therapeutics (MPLT)

• Market cap: $701M
• 1 day: -7.89%
• 5 days: -10.95%
• 1 month: -7.74%
• 3 months: -7.74%
• 6 months: -7.74%
• Year to date: -7.74%
• 1 year: -7.74%
• 5 years: -7.74%
• 10 years: -7.74%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.